We evaluated the frequency of moderate and severe adverse events following coadministration of seasonal influenza vaccine (SIV) versus placebo with COVID-19 vaccines among adults to support practice guidelines.  ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• October 2023

Respiratory syncytial virus (RSV) is a global cause of severe respiratory morbidity and mortality in infants. While preventive and therapeutic interventions are being developed, including antivirals, vaccines and monoclonal antibodies, little is known about the global molecular epidemiology of RSV. INFORM is a prospective, multicenter, global clinical study performed by ReSViNET to investigate the worldwide molecular diversity of RSV isolates collected from children less than 5 years of age. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2020
• June 2020

Influenza vaccination is recommended to protect mothers and their infants from influenza. Few studies have evaluated the association between maternal influenza vaccination and child mortality. We aimed to evaluate the association between in utero exposure to seasonal inactivated influenza vaccine (IIV) and mortality among young children. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2022
• June 2022

In preparation for the future arrival of a group A Streptococcus (GAS) vaccine, this study estimated the economic and health burdens of GAS diseases in New Zealand. The annual incidence of GAS diseases was based on extrapolation of the average number of primary healthcare episodes managed each year in general practices (2014-2016) and on the average number of hospitalizations occurring each year (2005-2014). Disease incidence was multiplied by the average cost of diagnosing and managing an episode of disease at each level of care to estimate the annual economic burden. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2021
• February 2021

Evidence suggests that children who had received an initial priming dose of whole-cell pertussis (wP) vaccine, rather than acellular pertussis (aP) vaccine, had a lower risk of developing IgE-mediated food allergy, the most common cause of anaphylaxis-related hospital presentations of childhood. ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2024
• January 2024

Jennifer Peter Kent Richmond J PC RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@telethonkids.org.au ...

• Telethon Kids Institute
• Projects

Investigators: Raphael Watt (student) This project will explore whether the metabolic products of a healthy gut microbiota support anti-microbial ...

• Telethon Kids Institute
• Projects
• Past projects

We are excited to announce the winners of our inaugural Illuminate Awards ...

• Giving at Telethon Kids
• Your impact
• Giving stories
• 2022
• May

Jonathan Carapetis AM JR AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@ ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2021
• June 2021

Our findings suggest that utilization of IL-7 by cTFH cells affects production of IgG2 antibodies to PPV23 antigens in some HIV patients ...

• Telethon Kids Institute
• Our research
• Reports and Findings
• 2019
• April 2019